Lv3
380 积分 2021-12-30 加入
An Observational Study of Patients With Chronic Lymphocytic Leukemia Treated With Fixed Duration Therapy in a 1L Setting in Canada
2天前
已完结
Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcome analysis of the CLL13/GAIA trial
4天前
已完结
Current Treatment of Double Refractory Chronic Lymphocytic Leukemia: A Focus on Novel Drugs
4天前
已完结
Pharmacological management of chronic lymphocytic leukemia: current and emerging therapies
13天前
已完结
Contemporary Management of Relapsed or Refractory Chronic Lymphocytic Leukemia
13天前
已完结
MRD-driven treatment strategies in CLL: Current practice, limitations, and emerging paradigms
27天前
已完结
How I treat patients with CLL after prior treatment with a covalent BTK inhibitor and a BCL-2 inhibitor
1个月前
已完结
Unmutated IGHV at diagnosis in patients with early stage CLL independently predicts for shorter follow-up time to first treatment (TTFT)
1个月前
已完结
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)
2个月前
已完结
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
2个月前
已完结
皖公网安备34019202002308
